Meningoccocal Disease
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Evaluation of the Antibody Persistence Beyond Five Years After Immunization With MenFiveTM (NmCV-5), a Pentavalent Meningococcal ACYWX Conjugate Vaccine (NCT07379151) | Serum Institute of India Pvt. Ltd. | 2026-05-05 |
| Antibody Persistence, and Safety and Tolerability of a Booster Dose of the Meningococcal B Vaccine After the Completion of the Vaccination Course in Study V72_28 (NCT01894919) | Novartis Vaccines | 2013-06-01 |
Track Meningoccocal Disease automatically
Every clearance here is in the API, with alerts when new ones post.